Follow
Annika Frank
Annika Frank
Unknown affiliation
Verified email at hhu.de
Title
Cited by
Cited by
Year
Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor
A Frank, DJ Kiss, GM Keserű, H Stark
Scientific Reports 8 (1), 12509, 2018
372018
Experimental models for the discovery of novel anticonvulsant drugs: focus on pentylenetetrazole-induced seizures and associated memory deficits
A Alachkar, SK Ojha, A Sadeq, A Adem, A Frank, H Stark, B Sadek
Current pharmaceutical design 26 (15), 1693-1711, 2020
362020
Studies on anticonvulsant effects of novel histamine H3R antagonists in electrically and chemically induced seizures in rats
A Alachkar, D Łażewska, G Latacz, A Frank, A Siwek, A Lubelska, ...
International journal of molecular sciences 19 (11), 3386, 2018
252018
From medicinal plant extracts to defined chemical compounds targeting the histamine H4 receptor: Curcuma longa in the treatment of inflammation
A Frank, S Abu-Lafi, A Adawi, JS Schwed, H Stark, A Rayan
Inflammation Research 66, 923-929, 2017
252017
The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive …
N Eissa, K Venkatachalam, P Jayaprakash, M Falkenstein, M Dubiel, ...
International journal of molecular sciences 22 (4), 1947, 2021
212021
Nature-inspired pyrrolo [2, 3-d] pyrimidines targeting the histamine H3 receptor
A Frank, F Meza-Arriagada, CO Salas, C Espinosa-Bustos, H Stark
Bioorganic & Medicinal Chemistry 27 (14), 3194-3200, 2019
162019
Novel meriolin derivatives as rapid apoptosis inducers
D Drießen, F Stuhldreier, A Frank, H Stark, S Wesselborg, B Stork, ...
Bioorganic & Medicinal Chemistry 27 (15), 3463-3468, 2019
152019
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
D Łażewska, A Olejarz-Maciej, D Reiner, M Kaleta, G Latacz, M Zygmunt, ...
International journal of molecular sciences 21 (10), 3411, 2020
142020
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease
J Godyń, P Zaręba, D Łażewska, D Stary, D Reiner-Link, A Frank, ...
Bioorganic Chemistry 114, 105129, 2021
112021
Guanidine Derivatives: How Simple Structural Modification of Histamine H3R Antagonists Has Led to the Discovery of Potent Muscarinic M2R/M4R Antagonists
M Staszewski, D Nelic, J Jończyk, M Dubiel, A Frank, H Stark, M Bajda, ...
ACS Chemical Neuroscience 12 (13), 2503-2519, 2021
102021
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
M Elek, N Djokovic, A Frank, S Oljacic, A Zivkovic, K Nikolic, H Stark
Archiv der Pharmazie 354 (6), 2000486, 2021
102021
Talipexole variations as novel bitopic dopamine D 2 and D 3 receptor ligands
L Stank, A Frank, S Hagenow, H Stark
MedChemComm 10 (11), 1926-1929, 2019
62019
Sequentially catalyzed three-component Masuda–Suzuki–Sonogashira synthesis of fluorescent 2-Alkynyl-4-(7-azaindol-3-yl) pyrimidines: Three palladium-catalyzed processes in a …
D Drießen, L Biesen, TJJ Müller
Synlett 32 (05), 491-496, 2021
52021
Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of …
J Godyń, P Zaręba, D Stary, M Kaleta, KJ Kuder, G Latacz, S Mogilski, ...
Molecules 28 (1), 238, 2022
32022
Biphenylalkoxyamine Derivatives–Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity
D Łażewska, P Zaręba, J Godyń, A Doroz-Płonka, A Frank, D Reiner-Link, ...
Molecules 26 (12), 3580, 2021
32021
Prior activation of 5-HT7 receptors modulates the conditioned place preference with methylphenidate
C Carbone, SLM Lo Russo, E Lacivita, A Frank, E Alleva, H Stark, L Saso, ...
Frontiers in Behavioral Neuroscience 13, 208, 2019
32019
New lead elements for histamine H3 receptor ligands in the pyrrolo [2, 3-d] pyrimidine class
C Espinosa-Bustos, A Frank, S Arancibia-Opazo, CO Salas, A Fierro, ...
Bioorganic & Medicinal Chemistry Letters 28 (17), 2890-2893, 2018
32018
Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine‐Independent and Chronic Itch
A Balzulat, WF Zhu, C Flauaus, V Hernandez‐Olmos, J Heering, ...
Advanced Science, 2307237, 2024
2024
Discovery of a new activator of Slack potassium channels with robust efficacy in models of histamine-independent and chronic itch
A Balzulat, WF Zhu, C Flauaus, V Hernandez-Olmos, J Heering, ...
bioRxiv, 2023.10. 05.560997, 2023
2023
Dual Targeting Ligands—Histamine H3 Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation
D Łażewska, A Siwek, A Olejarz-Maciej, A Doroz-Płonka, ...
Pharmaceutics 14 (10), 2187, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20